Literature DB >> 25081263

Draft Genome Sequence of Amycolatopsis mediterranei DSM 40773, a Tangible Antibiotic Producer.

Udita Mukherjee1, Anjali Saxena1, Rashmi Kumari1, Priya Singh1, Rup Lal2.   

Abstract

Amycolatopsis mediterranei DSM 40773 has been of special interest as successors of this strain are in use for the commercial production of rifamycin B. Here we present the draft genome sequence (~10 Mb) of this strain, which contains 108 contigs, 9,198 genes, and has a G+C content of 71.3%.
Copyright © 2014 Mukherjee et al.

Entities:  

Year:  2014        PMID: 25081263      PMCID: PMC4118066          DOI: 10.1128/genomeA.00752-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Amycolatopsis mediterranei DSM 40773 was derived from the parent strain isolated from the soil of pine arboretum at St. Raphael, France (1). At the time of isolation, this strain was classified as Streptomyces mediterranei (1), then as Nocardia mediterranei (2), and finally as Amycolatopsis mediterranei (3). This strain has remained of inordinate interest to researchers because of its ability to produce rifamycin B, whose semisynthetic derivatives are clinically used for the treatment of tuberculosis, leprosy, and AIDS related mycobacterial infections (4). Additionally, this strain has been subjected to a classical strain improvement program and successors of this strain are in use for the commercial production of rifamycin B (5). Along with the development of cloning vectors and transformation systems (6–10), a rifamycin biosynthetic gene cluster was also characterized from this strain (11). Here we present the draft genome sequence of A. mediterranei DSM 40773. The genome sequencing of strain DSM 40773 was carried out using an Illumina genome analyzer platform with the PCR-free method (12). The approximate genome size is 10,012,803 bp with over 100× genome coverage. It was assembled into 108 contigs using the ABySS 1.3.5 assembler (13) set at a k-mer size of 63. The average G+C content is 71.3%. The annotations were done on RAST server 4.0 (14) and the NCBI Prokaryotic Genomes Annotations Pipeline (PGAP) version 2 (http://www.ncbi.nlm.nih.gov/genomes/static/Pipeline.html). A total of 9,353 open reading frames (ORFs) falling into 24 clusters of orthologous groups (COGs) categories were found with COGs of the class R being most abundant. The draft genome was found to contain 9,198 genes, 9,100 coding sequences (CDSs), and 21 pseudogenes. 51 tRNA’s and 4 copies of the 16S rRNA genes were detected using RNAmmer 1.2 (15). It also contained 1,195 tandem repeats and 4 clustered regularly interspaced short palindromic repeat (CRISPR) elements. Despite being subjected to classical strain improvement, the rifamycin polyketide synthase (PKS) gene cluster of 90 kb was identical to that of A. mediterranei S699 (16, 17) and A. mediterranei U32 (18). Analysis further revealed that other than the reported 90-kb cluster (11), DSM 40773 contains 6 other PKSs. Besides that, 12 nonribosomal peptide synthetases (NRPS)-PKS gene clusters, along with 2 hybrid NRPS/PKS gene clusters were found using NRPS Predictor 2 (19) and the PKS/NRPS Analysis website (20). Based on average nucleotide identity, the draft genome of strain DSM 40773 was 99.99% identical to those of A. mediterranei S699 (16) and A. mediterranei U32 (18). However, the genome comparison of DSM 40773 with S699, revealed 196 single nucleotide polymorphisms (SNPs), of which there were 27 transversions and 169 transitions. It also harbors secondary metabolite gene clusters like butyrolactone, lantipeptide, terpene, bacteriocin, and ectoine. The whole-genome sequencing of strain DSM 40773 coupled with the genome sequences of A. mediterranei S699, A. mediterranei U32, and A. rifamycinica DSM 46095 (21) can now be used for developing better combinatorial approaches for the production of rifamycin analogs as demonstrated recently (22). Further, a deeper insight into the genomes rifamycin B producers will aid in further understanding the mutations or changes in the genomes of the current day industrial strains that produce rifamycin B as high as ~24 g/liter (5).

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. JMQJ00000000. The version described in this paper is the first version, JMQJ00000000.1.
  20 in total

1.  Development of cloning vectors and transformation methods for Amycolatopsis.

Authors:  Gauri Dhingra; Rekha Kumari; Shashi Bala; Swati Majumdar; Shweta Malhotra; Poonam Sharma; Sukanya Lal; John Cullum; Rup Lal
Journal:  J Ind Microbiol Biotechnol       Date:  2003-04-08       Impact factor: 3.346

2.  Construction of a hybrid plasmid capable of replication in Amycolatopsis mediterranei.

Authors:  R Lal; S Lal; E Grund; R Eichenlaub
Journal:  Appl Environ Microbiol       Date:  1991-03       Impact factor: 4.792

3.  Cloning and sequence analysis of the putative rifamycin polyketide synthase gene cluster from Amycolatopsis mediterranei.

Authors:  T Schupp; C Toupet; N Engel; S Goff
Journal:  FEMS Microbiol Lett       Date:  1998-02-15       Impact factor: 2.742

Review 4.  Regulation and manipulation of the gene clusters encoding type-I PKSs.

Authors:  R Lal; R Kumari; H Kaur; R Khanna; N Dhingra; D Tuteja
Journal:  Trends Biotechnol       Date:  2000-06       Impact factor: 19.536

5.  Complete genome sequence of the rifamycin SV-producing Amycolatopsis mediterranei U32 revealed its genetic characteristics in phylogeny and metabolism.

Authors:  Wei Zhao; Yi Zhong; Hua Yuan; Jin Wang; Huajun Zheng; Ying Wang; Xufeng Cen; Feng Xu; Jie Bai; Xiaobiao Han; Gang Lu; Yongqiang Zhu; Zhihui Shao; Han Yan; Chen Li; Nanqiu Peng; Zilong Zhang; Yunyi Zhang; Wei Lin; Yun Fan; Zhongjun Qin; Yongfei Hu; Baoli Zhu; Shengyue Wang; Xiaoming Ding; Guo-Ping Zhao
Journal:  Cell Res       Date:  2010-06-22       Impact factor: 25.617

6.  Development of an improved cloning vector and transformation system in Amycolatopsis mediterranei (Nocardia mediterranei).

Authors:  R Lal; R Khanna; N Dhingra; M Khanna; S Lal
Journal:  J Antibiot (Tokyo)       Date:  1998-02       Impact factor: 2.649

7.  Biosynthesis of the ansamycin antibiotic rifamycin: deductions from the molecular analysis of the rif biosynthetic gene cluster of Amycolatopsis mediterranei S699.

Authors:  P R August; L Tang; Y J Yoon; S Ning; R Müller; T W Yu; M Taylor; D Hoffmann; C G Kim; X Zhang; C R Hutchinson; H G Floss
Journal:  Chem Biol       Date:  1998-02

8.  A proposal for the transfer of Streptomyces mediterranei Margalith and Beretta 1960 to the genus Nocardia as Nocardia mediterranea (Margalith and Beretta) comb. nov.

Authors:  J E Thiemann; G Zucco; G Pelizza
Journal:  Arch Mikrobiol       Date:  1969

9.  NRPSpredictor2--a web server for predicting NRPS adenylation domain specificity.

Authors:  Marc Röttig; Marnix H Medema; Kai Blin; Tilmann Weber; Christian Rausch; Oliver Kohlbacher
Journal:  Nucleic Acids Res       Date:  2011-05-09       Impact factor: 16.971

10.  Draft Genome Sequence of the Rifamycin Producer Amycolatopsis rifamycinica DSM 46095.

Authors:  Anjali Saxena; Rashmi Kumari; Udita Mukherjee; Priya Singh; Rup Lal
Journal:  Genome Announc       Date:  2014-07-03
View more
  3 in total

1.  Conjugation of ϕBT1-derived integrative plasmid pDZL802 in Amycolatopsis mediterranei U32.

Authors:  Chen Li; Li Zhou; Ying Wang; Guoping Zhao; Xiaoming Ding
Journal:  Bioengineered       Date:  2017-01-03       Impact factor: 3.269

2.  Genetics and Genomics of the Genus Amycolatopsis.

Authors:  Rashmi Kumari; Priya Singh; Rup Lal
Journal:  Indian J Microbiol       Date:  2016-05-02       Impact factor: 2.461

3.  Draft Genome Sequence of Rifamycin Derivatives Producing Amycolatopsis mediterranei Strain DSM 46096/S955.

Authors:  Priya Singh; Rashmi Kumari; Udita Mukherjee; Anjali Saxena; Utkarsh Sood; Rup Lal
Journal:  Genome Announc       Date:  2014-08-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.